An endogenous inhibitor of cysteine and serine proteinases from spleen  by Brzin, J. et al.
Volume 138, number 2 FEBS LETTERS February 1982 
AN ENDOGENOUS INHIBITOR OF CYSTEINE AND SERINE PROTEINASES FROM SPLEEN 
J. BRZIN, M. KOPITAR, P. LO~NIKAR and V. TURK 
Department ofBiochemistry, J. Stefan Institute, E. Kardel/ University, L/ubl]ana, Yugoslavia 
Received 20 October 1981 ; revision received 11 January 1982 
1. Introduction 
Much attention has been paid to endogenous 
inhibitors of proteinases which have the property of 
inhibiting 2 different types of proteinases, such as 
cysteine proteinases, e.g., cathepsin B, H, L, S, papain 
[ 1-6,9] and the serine intracellular proteinases of
chymotrypsin type [2,7-9]. We have studied the 
inhibitory mechanism of this inhibitor, based on an 
active sulfhydryl group of the inhibitor which may 
interact with a disulphide bond of the inhibited pro- 
teinase. According to this property we named it 
serieystatin, i dicating its inhibitory property against 
serine and cysteine proteinases [10]. Multiple molecu- 
lar forms exist of this type of intracellular inhibitor 
[4,9]. Their Mr-values range from 11 000-13 000 
and, they differ in pI and intracellular location, and 
in inhibitory activity against various proteinases. 
This paper describes the techniques used for the 
purification of the cysteine cytosolic inhibitors from 
bovine spleen, as well as some of their characteristics. 
In a purification procedure we have taken advantage 
of high stability of this type of inhibitor in alkaline 
solutions. 
2. Materials and methods 
Spleen cytosolic inhibitors were prepared from 
fresh bovine spleen (100 g) which was cut up and 
cells squeezed out to avoid excessive damage. The 
ceils were suspended in 400 ml cold Hank's buffer, 
followed by centrifugation at 400 X g for 5 rain. This 
procedure was repeated 3 times to remove serum pro- 
teins. The rinsed cells were resuspended with a 1:3 
(v/v) ratio of Hank's solution and homogenized with 
a Teflon homogenizer under ice-cooling. The homog- 
enate was centrifuged (4°C) at 5000 × g for 15 min. 
The sediment was discarded and the supernatant 
further centrifuged at 50 000 X g for 45 min. This 
supernatant, cytosol (freed of nuclei and granules) 
was used in our experiments. 
Purified samples of cathepsin B, H and S were pre- 
pared from bovine spleen by covalent coupling to 
commercial thiol-Sepharose [ 11 ]. Papain was supplied 
by Sigma (St Louis) and trypsin from NBC (Ohio). 
Sepharose 4B, thiol-Sepharose, Sephadex G-75 and 
G-50 and DEAE-Sephacell were supplied by Pharmacia 
(Sweden). 
2.1. Assays 
The activities of cathepsin B and papain were 
determined using Bz Arg Nap (Sigma) as substrate, 
and the activity of cathepsin H was determined with 
Leu Nap (Sigma) as substrate, according to [12]. 
Cathepsin Swas assayed with azocasein as substrate, 
following [11 ]. Trypsin activity was measured with 
Bz Arg Na as substrate following [13]. 
Inhibitor activity was assayed under the same con- 
ditions as those used for proteinase activities, but 
with inhibitor sample in place of some of the buffer. 
The enzyme was maintained ata constant level 
(10-25/1l) in 0.2 N phosphate buffer at pH 6.5 with 
the addition of variable quantities of inhibitor 
(25-200/A). The total volume of buffer, enzyme and 
inhibitor was 0.25 ml. After 10 min preincubation at
room temperature, the samples were assayed on sub- 
strates for the determination f the residual enzyme 
activity. 
2.2. Other methods 
The M r of the inhibitor was estimated by gel 
filtration on a Sephadex G-50 Superfine column 
(I × 60 cm). Standards were ovalbumin, trypsinogen, 
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cytochrome c and pancreatic trypsin inhibitor (Sigma). 
Disc gel electrophoresis of inhibitor samples was 
done as in [14] on 6 cm cylindrical gels of 7% acryla- 
mide in 25 mM Tris, 0.2 M glyeine OH 8.4). Gels 
were stained for protein with Coomassie blue. 
The isodectric point of the inhibitor samples was 
determined on an apparatus used for analytical iso- 
electric focusing (Desaga), using 5% polyacrylamide 
plates of 9 X 16 em, with carrier ampholines of 
pH 2 -8  and by isoelectric focusing. In this case, 
pH 3.5-10.0 carrier ampholite in an LKB 8101 col- 
umn in sucrose density gradient were used. 
Protein was assayed as in [15]. The dissociation 
constant of the inhibitor, Ki, isolated from papain 
Sepharose, was determined from Dixon plots [16]. 
2.3. Inactivation of inhibitor 
The effect of alkaline treatment on the activity of 
inhibitor samples was tested by preincubating the 
inhibitor samples at 37°C in 0.2 M Tris buffer 
(pH 12.0) for 10 min. After the incubation the mix- 
tures were readjusted to pH 6.5 with 5 M HC1. Heat 
treatment was performed at the same concentration 
of inhibitor samples, for the same time (10 min)in 
0.2 N phosphate buffer (pH 6.5). Residual inhibitory 
activity was tested against papain, cathepsin B and 
cathepsin H. 
2.4. Gel filtration, ion-exchange chromatography and 
affinity chromatography 
The concentrated cytosol (alkaline activated) was 
dialyzed against 20 vol. 0.01 M Tris-HC1, containing 
0.3 M NaC1 (pH 7.5) and gel filtered on Sephadex 
G-75 column (8 × 100 cm). Pooled fractions of the 
low M r inhibitory protein were concentrated by ultra- 
filtration through a UM-10 membrane and dialyzed 
against 20 vol. 2 mM Tris-HCl (pH 7.5). The dialy- 
sand was divided in half and chromatographed twice 
on a DEAE-Sephacel column (3 × 30 cm). Inhibitory 
proteins eluted with the starting buffer and with a 
linear gradient of NaCI (0.00-0.15 M), total vol. 1 litre. 
Papain coupled to Sepharose 4B (1.5 g) was pre- 
pared following the Pharmacia pamphlet. Papain was 
dissolved in 0.1 M sodium bicarbonate (pH 8.5) at 
6 mg protein/ml. The washed gel was suspended in
5 ml ligand solution and shaken for 24 h at 4°C. The 
yield of papain bound to Sepharose was ~70% (mg 
protein) and 75% of enzyme activity. Papain- 
Sepharose was finally washed with 2 mM Tris buffer 
(pH 7.5). 
3. Results 
Cytosol was adjusted to pH 12 with 5 M NaOH at 
room temperature. After 10 min it was readjusted to 
pH 7.5 with 5 M HC1 and the precipitate formed was 
removed by centrifugation at5000 X g for 15 min. 
This final supernatant was used in purification. Cyto- 
sol alkalization resulted in ~17-fold increase (release) 
of inhibitory activity, from 300 IU to 5200 IU 
(table 1 A) and therefore we term it the 'alkaline acti- 
vating step of cytosol'. 
Table 1 
Purification of sericystatin from spleen 
Stage Vol. Protein Act. Spec. act. Yield 
(ml) (mg/ml) (IU) (IU/mg) (%) 
A: Cytosol 300 20 300 0.05 
Cytosol 
pH 12-treated 260 7.2 5200 2.9 100 
Sephadex G-75 119 0.6 2100 29.1 40 
DEAE-Sephacel 
(7 peaks) 60 0.3 1500 83.3 a 29 
B: Peak 4 from 
DEAE-Sephacel 6.2 0.3 228 123 100 
Affinity chrom. 7.6 0.04 172 570 77 
a Average specific activity of 7 eluted inhibitory peaks from DEAE-Sephacel; the val- 
ues vary from 52-135 IU/mg 
IU, inhibitory units based on papain activity toward Bz Arg Nap; 1 inhibitory unit -- 
decrease of ZXA s~o f 0.1/10 min 
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The results of the purification procedure are shown 
in table 1A,B. By ultrafiltration (UM-10) concen- 
trated cytosol was dialyzed, and then chromato- 
graphed on a Sephadex G-75 column. Papain inhibitory 
proteins eluted in 2 peaks. The fractions from both 
peaks were also tested on trypsin and a smaller inhib- 
itory activity was noted in fractions of ~5000 M r and 
8000 M r. The small amount (~10%) of high M r 
papain inhibitory proteins was discarded and the low 
M r inhibitory fractions, from the major peak with 
~15 000 M r were concentrated (UM-10), and applied 
on a DEAE-Sephacel column (fig.l). A minor part 
(15-20%) of the inhibitory activity eluted with non- 
adsorbed material in peaks 1 and 2. After addition of 
a NaC1 gradient, he main part of the inhibitory activ- 
ity eluted in peaks 3-7. The total yield of all 7 inhib- 
itory peaks from the DEAE-Sephacel column was 
~30%, in comparison to the total inhibitory activity 
of the alkaline activation step, (table 1A). The eluted 
fractions of inhibitory peaks 1-4 and 7 were tested 
on cathepsin B, H, S and papain. The inhibitors of 
separated peaks differ considerably in their inhibitory 
activity against the enzymes tested (fig.2, table 2). 
The inhibitor eluted in peak 1 acted most efficiently 
against all 4 tested enzymes, whereas the inhibitors of 
all other peaks did not inhibit cathepsin B. Inhibitor 
eluted in peak 2 showed only a weak inhibition against 
cathepsin H and papain. 
The isoelectric point of the proteins eluted in the 
7 inhibitory peaks, determined by analytical isoelec- 
tric focusingwere: 7.0-6.8 (peak 1);6.7-6.5 (peak 2); 
5.8-5.2 (peaks 3-6); and 4.8-4.6 (peak 7). The esti- 
mated M r values of these isoinhibitors were ~13 000. 
Table 2 shows the alkaline (pH 12) and heat-stabil- 
ity of the inhibitors of peaks 1 and 4. Both inhibitors 
were relatively stable at pH 12, but they differ in heat- 
stability. The inhibitor of peak 1 showed thermal 
instability; significant loss of activity was noted 
igainst all 3 tested enzymes. 
The protein inhibitor of peak 4 from DEAE- 
Sephacel was further purified on papain-Sepharose 
(fig.3). Non-specific proteins were eluted with start- 
ing buffer, containing 3 M NaC1. The inhibitor was 
eluted with 0.1 M Tris (pH 10.5) in fractions 45-52. 
Each eluted fraction was immediately readjusted from 
pH 10.5 to pH 6.5 with 5 M HC1. The specific activity 
in this purification step increased 4.7-fold (table 1B), 
from 123 IU/mg to 570 IU/mg, and the yield of 
~77%, is rather high. The gel electropherogram of 
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Fig.1. DEAE-Sephacel chromatography of pooled and concentrated inhibitory fractions from Sephadex G-75:0.1 ml fraction was 
assayed against 3 t~g papain for inhibitory activity; ( ) protein; ( - - - )  % inhibition. 
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Fig.2. Inhibition of cathepsin B ( ), cathepsin H ( . . . . . .  ), 
cathepsin S ( - - - )  and papaln (...... ) with increasing amounts 
of inhibitors from peaks 1-4  and 7, eluted from DEAE- 
Sephacel: ordinate, residual activity (% of control); abscissa, 
amount of inhibitor added (pl). 
Fig.3. Profile of affinity chromatography on papain- 
Sepharose. Combined fraction 82 and 83 (peak 4) from 
DEAE-Sephacel were applied: ( ) protein; ( - - - )  % 
inhibition of papain. 
(2.9 IU/mg) to the final purification step of the inhib- 
itor (570 IU/mg) v~as 197-fold, whereas from the 
starting cytosol (0.5 IU/mg) it was 11 400-fold. 
The inhibitor, bound to papain-Sepharose, can be 
eluted also by 0.02 M NaOH (pH 12) or by GSSG 
(0.5 mg/ml in 0.2 N phosphate buffer (pH 7.0) In a 
former experiment, by pH 12 treatment (corrected 
back to pH 7.0) inhibitor protein possessed inhibitory 
activity, but the yield was much smaller (~40%). In 
case of GSSG treatment, the eluted inhibitor protein 
was inactive, because it was eluted in the form of an 
oxidized glutathione :inhibitor complex, as reported 
in [10]. 
The purified inhibitor non-competitively inhibited 
papain, tested on Bz Arg Nap substrate, and its K i 
was 6.5 X 10 -9 M. 
Table 2 
Effect of heat (90 ° C) and pH 12 treatments on the inhibitory activity of 
isoinhibitors i olated from DEAE-Sephacel 
Sample Treatment Cathepsin B Cathepsin H Papain 
(3 ug) (5 Pg) (3 pg) 
Inhibitor Control 79 73 76 
(12 pg) from pH 12 46 53 66 
peak 1 90°C 14 25 36 
Inhibitor Control 0 87 94 
(12 pg) from pH 12 0 55 66 
peak 4 90°C 0 85 93 
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Control = inhibitor sample preincubated for 10 min at room temperature in buffer 
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4. Discussion References 
Leucocytes [2,7,9,10], spleen [2,8], liver [4,6], 
skin [1] and other tissues contain not only sericy- 
statin with an acid pI, but also an isoform with a pI 
near neutrality [9,10]. It was already known that 
these protein isoinhibitors inhibit intracellular protein- 
ases of cysteine and serine type. We had also found 
that cathepsin D does not inactivate (degrade) sericy- 
statin, whereas it does inactivate other types of intra- 
cellular inhibitors, such as the inhibitors of  urokinase 
[17,18] and elastase [17]. 
The experiments including gel fdtration, anion 
exchange chromatography and affinity chromatog- 
raphy of the activated (treated to pH 12) spleen cyto- 
sol revealed the presence of 7 inhibitory proteins of 
~13 000M r and pI-values from pH 4.8-7.0. These 
inhibitors differ not only in pI but also in their activ- 
ity against various tested cysteine proteinases and in 
heat stability. 
It is evident hat the 'alkaline activating step of  
cytosol' (table 1 A) is very important in the generation 
(release) of inhibitor activity. The total inhibitory 
activity increased ~17-fold. Thus the increase of 
inhibitory activity may be based on dissociation of 
enzyme-inhibitor complexes, and on inactivation 
(precipitation) of  cysteine and chymotrypsin-like 
neutral proteinases. The dissociation of such com- 
plexes (cysteine proteinase-sericystatin) has been 
confirmed: cysteine proteinases can be replaced from 
their complexes by the action of chymotrypsin-like 
neutral proteinase or by oxidized glutathiohe [ 10]. 
A similar mechanism of enzyme-inhibitor com- 
plex dissociation has been found for collagenases 
[19,20], and a neutral proteinase [21 ]. Concerning 
the action of cysteine [22] and chymotrypsin-like 
neutral proteinase [23] in normal and pathological 
events it is likely that these inhibitors play a protec- 
tive role in elimination of unwanted proteolysis. This 
type of intraceUular inhibitor has the ability to inhibit 
the growth of metastases in vivo [24], as well as the 
growth of cells in colonies in vitro [9]. 
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